A 52-year-old woman from Delhi presents with progressive weakness, bone pain, and recurrent kidney stones over 6 months. She reports nausea and constipation. Laboratory investigations show: serum calcium 11.2 mg/dL (normal 8.5–10.2), serum phosphate 2.8 mg/dL (normal 2.5–4.5), serum creatinine 1.4 mg/dL, 24-hour urinary calcium 380 mg/day (normal <250), and intact PTH 185 pg/mL (normal 10–65). Abdominal ultrasound reveals a 1.2 cm hypoechoic lesion in the lower pole of the right parathyroid gland. What is the primary mechanism responsible for hypercalcemia in this patient?

Explanation

## Clinical Context This patient presents with **primary hyperparathyroidism (PHPT)** due to a parathyroid adenoma (hypoechoic lesion on ultrasound). The combination of hypercalcemia + markedly elevated PTH (185 pg/mL) + elevated urinary calcium + low-normal phosphate is pathognomonic. ## Primary Mechanism of Hypercalcemia in PHPT **Key Point:** While PTH acts through three coordinated mechanisms (renal calcium reabsorption, vitamin D–mediated intestinal absorption, and bone resorption), the **primary and quantitatively dominant** mechanism responsible for hypercalcemia in established PHPT is **increased osteoclastic bone resorption via PTH-mediated RANKL expression on osteoblasts**. ### How PTH Drives Bone Resorption: - PTH binds PTH1 receptors on **osteoblasts** - Osteoblasts upregulate **RANKL (Receptor Activator of NF-κB Ligand)** - RANKL binds RANK on osteoclast precursors → osteoclast differentiation and activation - Activated osteoclasts resorb bone matrix → release of calcium and phosphate into circulation - This is the **largest net contributor** to the hypercalcemia seen in chronic PHPT ### Why Bone Resorption Is Primary: In chronic PHPT (as in this 6-month history), bone resorption accounts for the majority of the calcium load entering the extracellular fluid. Studies using calcium kinetics show that skeletal calcium release is the dominant source of hypercalcemia in PHPT (Harrison's Principles of Internal Medicine, 21st ed., Chapter on Hypercalcemia; Guyton & Hall Textbook of Medical Physiology). ## Why the Other Options Are Incorrect - **Option A (Renal DCT reabsorption):** PTH does increase calcium reabsorption in the DCT via TRPV5 channels and calbindin-D₂₈ₖ. However, this is a *secondary/supporting* mechanism. Notably, this patient's urinary calcium is **elevated (380 mg/day)**, indicating that the filtered calcium load overwhelms renal reabsorptive capacity — renal reabsorption is NOT the primary driver of hypercalcemia here. - **Option B (PTH-independent vitamin D upregulation):** Incorrect. Intestinal calcium absorption in PHPT is PTH-*dependent* (PTH stimulates renal 1α-hydroxylase → ↑ 1,25-dihydroxyvitamin D₃ → intestinal absorption). The phrase "PTH-independent" makes this factually wrong. - **Option D (Volume depletion from diarrhea):** The stem describes constipation, not diarrhea. This mechanism is irrelevant and factually inconsistent with the clinical scenario. ## Integrated Physiology Table | Mechanism | Onset | Net Contribution to Hypercalcemia | |-----------|-------|-----------------------------------| | Renal Ca reabsorption (DCT/CD) | 15–30 min | Minor (filtered load overwhelms) | | Intestinal Ca absorption (via 1,25-VitD) | 4–6 hours | Moderate | | **Osteoclastic bone resorption (RANKL)** | **Hours–days** | **Major — primary mechanism** | **Clinical Pearl:** The elevated 24-hour urinary calcium (380 mg/day) in this patient does NOT contradict PTH-mediated reabsorption — it reflects the massive calcium load from bone resorption exceeding tubular reabsorptive capacity (filtered load effect). PTH reabsorbs what it can, but the skeletal calcium release is so large that urinary calcium still rises. **High-Yield Mnemonic:** In PHPT, **BONE is the bank** — PTH withdraws calcium from the skeletal reservoir via RANKL-driven osteoclast activation, making bone resorption the primary mechanism of hypercalcemia.